Ποια είναι η τιμή για PharmaSGP Holding SE (PSG)

Η τιμή για PharmaSGP Holding SE (PSG) είναι $34.40

Ποια είναι η κεφαλαιοποίηση αγοράς για PharmaSGP Holding SE (PSG)

Η κεφαλαιοποίηση αγοράς για PharmaSGP Holding SE (PSG) είναι $396.01M

PharmaSGP Holding SE (PSG) Δείκτης P/B

Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.

Έτος	Δείκτης P/B	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

Δείκτης P/B

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	Δείκτης P/B	Διαφορά Δείκτη P/B	Χώρα
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.5341	-	IN
Galderma Group AG GALD.SW	-	-	CH

Εταιρεία

Δείκτης P/B

Διαφορά Δείκτη P/B

Χώρα